• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

ValitaCell Ltd.

ValitaCell’s mission is to accelerate the pace and reduce the cost of manufacturing innovative medicines. We are focused on enabling our biopharmaceutical customers to bring medicines to the patients that need them most, in the shortest length of time. The majority of drugs that advance to clinical trial fail before they make it to the market. This failure increases costs and delays life-saving treatments for patients. Our team is focused on creating analytical technologies that empower scientists with rich cell data and insights earlier in the drug discovery and development process. We are committed to advancing human healthcare worldwide. *

 

	Start	2022-09-13 existent
	Group	Danaher (Group)
	Industry	laboratory automation equipment
	Industry 2	ValitaTiter (ValitaCell)
	Person	Clifford, Jerry (ValitaCell 202209 CEO + Co-Founder)
	Region	Dublin
	Country	Ireland, Republic of
	Street	NIBRT, Fosters Avenue, Mount Merrion, Blackrock
	City	A94 X099 Dublin
	Tel	+353-1-2158130
		Address record changed: 2022-09-27
Basic data	Employees	n. a.
		* Document for �About Section�: Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin.
		Record changed: 2022-09-27

Advertisement

More documents for Danaher (Group)

• [1] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [2] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [3] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
• [4] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [5] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....
• [6] Scitara Corporation. (6/30/21). "Press Release: Scitara Corporation Unleashes Universal Connectivity to Redefine Lab of the Future". Marlborough, MA....
• [7] AB Sciex (d/b/a Sciex). (6/17/21). "Press Release: Sciex OS Introduces New Software with OneOmics Suite and Molecule Profiler App". Framingham, MA....
• [8] Danaher Corporation. (6/17/21). "Press Release: Danaher to Acquire Aldevron". Washington, DC....
• [9] AB Sciex (d/b/a Sciex). (6/17/21). "Press Release: Sciex Presents New Accurate Mass instrument, the ZenoTOF 7600 System". Framingham, MA....
• [10] Biognosys AG. (6/15/21). "Press Release: Biognosys Announces New Release of Spectronaut". Schlieren....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.